News

ProKidney's Major Step in Chronic Kidney Disease Treatment Announced

ProKidney's Major Step in Chronic Kidney Disease Treatment Announced

ProKidney Presents Groundbreaking Research at ASN Kidney Week 2025

In a significant development for chronic kidney disease (CKD) treatment, ProKidney Corp. (Nasdaq: PROK) proudly announces the selection of two vital abstracts for presentation at the esteemed American Society of Nephrology’s (ASN) Kidney Week 2025. Set to take place from November 6 to 9 in Houston, Texas, this event underscores the company’s commitment to advancing therapeutic options for patients suffering from CKD.

Key Presentations to Highlight Innovative Research

The abstracts accepted for this year’s Kidney Week showcase exciting advancements in ProKidney's research portfolio. The anticipation surrounds the late-breaking poster that details the results of the Phase 2 REGEN-007 study.

Presentation Details of the Late-Breaking Study

The study titled Renal Autologous Cell Therapy in Diabetes and CKD (Phase 2 REGEN-007 Study Results) will be featured during a dedicated session for late-breaking science posters from 10:00 AM to 12:00 PM CST. Attendees can find this groundbreaking research on Poster Board #: TH-PO1203.

Exploring Inflammatory Profiles with the Other Presentation

Additionally, ProKidney will present another poster titled Cell-Specific Inflammatory Profile Characterization of the Cell Therapy Candidate Rilparencel. This presentation is scheduled for the same day and time as the late-breaking session, positioned on Poster Board #: TH-PO0575. This presentation is expected to contribute valuable insights regarding the inflammatory profiles associated with ProKidney's therapeutic candidates.

Post-Event Availability and Access

For those unable to attend the event, fear not! ProKidney will make the poster presentations available on the company’s official website following the conference. This will provide an opportunity to explore the groundbreaking findings in detail and understand more about the promising advancements in CKD therapies.

About ProKidney and Its Innovations

Founded in 2015, ProKidney is dedicated to transforming CKD treatment through innovative cellular therapy solutions. The company’s lead product candidate, rilparencel (also known as REACT), represents a revolutionary approach in regenerative medicine with a patented, proprietary design. Currently, rilparencel is being studied in the ongoing Phase 3 REGEN-006 (PROACT 1) study, which aims to evaluate its effectiveness in preserving kidney function among patients with advanced CKD and type 2 diabetes.

Contact ProKidney for More Information

For further inquiries about ProKidney’s advancements or research, interested parties can reach out to:

ProKidney Contact

Ethan Holdaway
Email: Ethan.Holdaway@prokidney.com

Media Contact

Audra Friis
Email: audrafriis@sambrown.com

Investor Relations Contact

Daniel Ferry
Email: Daniel@lifesciadvisors.com

Frequently Asked Questions

What is ProKidney Corp. known for?

ProKidney Corp. specializes in developing innovative cellular therapies aimed at treating chronic kidney disease.

When is ASN Kidney Week 2025?

ASN Kidney Week 2025 will occur from November 6 to 9 in Houston, Texas.

What are the titles of the presentations by ProKidney?

ProKidney will present two abstracts: one on renal autologous cell therapy and another on inflammatory profile characterization related to its cell therapy candidate rilparencel.

Will the poster presentations be available after ASN Kidney Week?

Yes, ProKidney will make the poster presentations available on its official website following the event.

How can I contact ProKidney for more information?

You can contact ProKidney via email through the provided contacts for any inquiries or information regarding their research and innovations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 6

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 6

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 7

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 11

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 4

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
Supply Maverick Simplifies Global Shipping Processes

Updated Category News Views 5

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Continue Reading
Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 4

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading

Top 5 Most Recently Viewed Articles

Investor Concerns on Grab Holdings’ Economic Positioning

Updated Category News Views 238

Understanding Grab Holdings in Today's Market Adam Khoo, a notable entrepreneur from Southeast Asia, has recently raised some eyebrow-raising comments regarding the investment potential of Grab Holdings Ltd. (NASDAQ: GRAB). With the company’s stock climbing 8.16%, reaching $5.30, and reflecting a 51.86% increase over the past year, many investors are questioning the...

Continue Reading
Explore JOYIN's Innovative Toy Brands at Spielwarenmesse 2026

Updated Category News Views 142

Discover JOYIN's Presence at Spielwarenmesse 2026 At the renowned Spielwarenmesse 2026, JOYIN is set to unveil its impressive array of toy solutions tailored for retailers and distributors. With a focus on quality and innovation, JOYIN's participation highlights their commitment to serving the global toy market effectively. Introducing JOVA: The Core Toy Brand Platform...

Continue Reading
Celebrating John P. Lynes: Neurosurgeon Excellence Recognized

Updated Category News Views 229

John P. Lynes Achieves Pinnacle Lifetime Membership Recently recognized in The Inner Circle, John P. Lynes, MD, has been awarded the esteemed Pinnacle Lifetime Membership for his outstanding contributions to the field of Brain and Spine Surgery. Professional Background and Specialization Dr. Lynes is a distinguished neurosurgeon with expertise in treating tumors of the...

Continue Reading
Viral Nation Unveils Enhanced Version of Secure Solution

Updated Category News Views 364

Viral Nation Unveils Enhanced Version of Secure Solution Viral Nation, a prominent global social media marketing and creator agency, is excited to announce a significant update to its innovative AI-powered brand reputation solution, Secure. This update aims to help brands identify brand safety blind spots effectively while ensuring they make well-informed influencer...

Continue Reading
Tripadvisor, Inc. Reports Impressive Q4 and Full Year Earnings

Updated Category News Views 222

Tripadvisor, Inc. Earnings Overview Tripadvisor, Inc. has recently released its earnings report for the fourth quarter and the entirety of 2024, showcasing significant progress and growth. As a leading travel company, Tripadvisor operates a versatile portfolio that connects travelers to inspiring experiences. Fourth Quarter Highlights The fourth quarter results reflect...

Continue Reading